BioCatalyst

ERAS — Erasca, Inc. catalysts

1 verified catalyst event(s) for Erasca, Inc. (ticker ERAS). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-11-01 — A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanc · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-01
in 4mo
ESTIMATED
 READOUT
A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients W
Phase 1/2 · Advanced or Metastatic Solid Tumors
 ERAS Erasca, Inc. ERAS-007, ERAS-601 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.